College Point, New York Clinical Trials

A listing of College Point, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 558 clinical trials
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia (ATLAS-NEO)

This is a multicenter, multinational, open-label, one-way cross-over, Phase 3, single-arm study for treatment of hemophilia. The purpose of this study is to measure the frequency of treated bleeding episodes with fitusiran in male adult and adolescent (≥12 years old) participants with hemophilia A or B, with or without inhibitory …

Northwell Health Hemostasis and Thrombosis Center Site Number : 8400015
 (8.9 away) Contact site
  • 0 views
  • 24 May, 2024
  • +53 other locations
Systematic Evaluation of Ablation Techniques for Non-Paroxysmal Atrial Fibrillation.

The purpose of this study is to evaluate the safety and effectiveness of empirical posterior wall isolation (PWI), left atrial appendage electrical isolation (LAAEI) and coronary sinus isolation (CSI) when compared to pulmonary vein isolation (PVI) alone: PVI alone, PVI + PWI, PVI + PWI + LAAEI, PVI + PWI …

left ventricular dysfunction
chest pain
pulmonary vein isolation
paroxysmal atrial fibrillation
dyspnea
Montefiore Medical Center
 (6.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients

A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.

life support
resuscitation
induced hypothermia
hypothermia
coma
NYP Columbia University Medical Center
 (6.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +12 other locations
Manhattan Vision Screening and Follow-Up Study

The investigators are conducting a 5-year prospective, cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved, vulnerable New York City residents living in affordable housing buildings in Harlem and Washington Heights.

vision screening
Columbia University
 (6.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Families Children and Teachers Thriving Together

The current study examines the impact of ParentCorps in high-poverty district schools in New York City (NYC). The study is conducted within the context of the NYC Department of Education (DOE) Pre-K Thrive initiative. As part of this initiative, the Center for Early Childhood Health and Development (CEHD) at NYU …

inspire
cehd
NYU Langone Health
 (7.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

aphasia
pick's disease
progranulin
dementia
Irving Institute for Clinical and Translational Research
 (6.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +46 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

covid-19
g6pd
SARS
cervical cap
electrocardiogram
Coronavirus Research Institute-Testing Site-
 (6.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

migraine
lasmiditan
ly573144
headache
treatment regimen
Care Access Research - Bronx
 (4.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +162 other locations
V6.3 Additional &QA123  

Test Comment here

hjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhj hjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhj hjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhj hjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhjhj
 (8.2 away)
  • 0 views
  • 24 Aug, 2023
  • +3 other locations
test002  

qa12

as
 (7.3 away)
  • 0 views
  • 22 Dec, 2022
  • +4 other locations